282
Views
2
CrossRef citations to date
0
Altmetric
Review

The Role of the Pharmacist in the Care of Patients with Chronic Pain

, , , ORCID Icon, &
Pages 33-41 | Published online: 30 Apr 2021

References

  • Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11(1):770. doi:10.1186/1471-2458-11-77021978149
  • Canadian Pain Task Force. Chronic pain in Canada: laying a foundation for action. Health Canada; 2019. Available from: https://www.canada.ca/content/dam/hc-sc/documents/corporate/about-health-canada/public-engagement/external-advisory-bodies/canadian-pain-task-force/report-2019/canadian-pain-task-force-June-2019-report-en.pdf. Accessed 42, 2021.
  • Loeser JD. Pain and suffering. Clin J Pain. 2000;16(2 Suppl):S2–S6. doi:10.1097/00002508-200006001-0000210870733
  • Nicol AL, Sieberg CB, Clauw DJ, Hassett AL, Moser SE, Brummett CM. The association between a history of lifetime traumatic events and pain severity, physical function, and affective distress in patients with chronic pain. J Pain. 2016;17(12):1334–1348. doi:10.1016/j.jpain.2016.09.00327641311
  • Katz L, Patterson L, Zacharias R. Evaluation of an interdisciplinary chronic pain program and predictors of readiness for change. Can J Pain. 2019;3(1):70–78. doi:10.1080/24740527.2019.1582296
  • Marra CA, Grubisic M, Cibere J, et al. Cost-utility analysis of a multidisciplinary strategy to manage osteoarthritis of the knee: economic evaluation of a cluster randomized controlled trial study. Arthritis Care Res (Hoboken). 2014;66(6):810–816. doi:10.1002/acr.2223224249680
  • Bruhn H, Bond CM, Elliott AM, et al. Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open. 2013;3(4):e002361. doi:10.1136/bmjopen-2012-002361
  • Canadian Pain Task Force. Working together to better understand, prevent and, manage chronic pain: what we heard. Health Canada; 2020. Available from: https://www.canada.ca/content/dam/hc-sc/documents/corporate/about-health-canada/public-engagement/external-advisory-bodies/canadian-pain-task-force/report-2020-rapport/report-2020.pdf. Accessed 42, 2021.
  • Thapa P, Lee SWH, Kc B, Dujaili JA, Mohamed Ibrahim MI, Gyawali S. Pharmacist-led interventionon chronic pain management: A systematic review and meta-analysis. Br J Clin Pharmacol. Jan 24 2021; doi:10.1111/bcp14745
  • Dole EJ, Murawski MM, Adolphe AB, Aragon FD, Hochstadt B. Provision of pain management by a pharmacist with prescribing authority. Am J Health Syst Pharm. 2007;64(1):85–89. doi:10.2146/ajhp06005617189585
  • Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–584. doi:10.1111/j.1526-4637.2006.00254.x17883742
  • Jacobs SC, Son EK, Tat C, Chiao P, Dulay M, Ludwig A. Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014–March 31, 2015. Subst Abus. 2016;37(1):15–19. doi:10.1080/08897077.2015.112952726675444
  • Strand MA, Eukel H, Burck S. Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk. Res Social Adm Pharm. 2019;15(8):1032–1036. doi:10.1016/j.sapharm.2018.07.01130031696
  • Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Evaluation of community pharmacists’ roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Prim Health Care Res Dev. 2018;19(6):598–604. doi:10.1017/s146342361800014229551098
  • Tabeefar H, Chang F, Cooke M, Patel T. Community pharmacists and chronic pain: a qualitative study of experience, perception, and challenges. Can J Pain. 2020;4(3):29–39. doi:10.1080/24740527.2020.1749516
  • Patel T, Chang F, Mohammed HT, et al. Knowledge, perceptions and attitudes toward chronic pain and its management: a cross-sectional survey of frontline pharmacists in Ontario, Canada. PLoS One. 2016;11(6):e0157151. doi:10.1371/journal.pone.015715127270723
  • Hartung DM, Hall J, Haverly SN, et al. Pharmacists’ role in opioid safety: a focus group investigation. Pain Med. 2018;19(9):1799–1806. doi:10.1093/pm/pnx13929016883
  • Giannitrapani KF, Glassman PA, Vang D, et al. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC Fam Pract. 2018;19(1):107. doi:10.1186/s12875-018-0783-929970008
  • Safer Healthcare Now. Best possible medication history interview guide. Available from: https://www.ismp-canada.org/download/MedRec/SHN_medcard_09_EN.pdf. Accessed 42, 2021.
  • Finnerup NB. Nonnarcotic methods of pain management. N Engl J Med. 2019;380(25):2440–2448. doi:10.1056/NEJMra180706131216399
  • Moulin D, Boulanger A, Clark AJ, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014;19(6):328–335. doi:10.1155/2014/75469325479151
  • Busse JW, Craigie S, Juurlink DN, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–E666. doi:10.1503/cmaj.17036328483845
  • Holmquist GL. Opioid metabolism and effects of cytochrome P450. Pain Med. 2009;10(suppl_1):S20–S29. doi:10.1111/j.1526-4637.2009.00596.x
  • Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. doi:10.1371/journal.pmed.100239628972983
  • Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760. doi:10.1136/bmj.j76028292769
  • Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013;13(4):533–540.24358002
  • Haanpää ML, Gourlay GK, Kent JL, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85(3 Suppl):S15–S25. doi:10.4065/mcp.2009.0645
  • Klivinyi C, Bornemann-Cimenti H. Pain medication and long QT syndrome. Korean J Pain.. Ann Acad Med Singapore. 2018;31(1):3–9.doi:10.3344/kjp.2018.31.1.3
  • Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129–138.8080219
  • Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16(Suppl 1):S32–6. doi:10.1111/pme.1291426461074
  • Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–112. doi:10.1111/j.1526-4637.2005.05031.x15773874
  • Nielsen S, Picco L, Kowalski M, et al. Routine opioid outcome monitoring in community pharmacy: outcomes from an open-label single-arm implementation-effectiveness pilot study. Res Social Adm Pharm. 2020;16(12):1694–1701. doi:10.1016/j.sapharm.2020.02.00932273255
  • Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1–2):137–143. doi:10.1016/j.drugalcdep.2010.02.01720347232
  • Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94(3):135–140.7778330
  • Regier L. Opioid Tapering Template. RxFiles; 2017.
  • Patterson AL, Gritzner S, Resnick MP, Dobscha SK, Turk DC, Morasco BJ. Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain. 2012;13(3):285–292. doi:10.1016/j.jpain.2011.11.00822325299
  • Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology. 2010;113(4):977–992. doi:10.1097/ALN.0b013e3181ebdaf920864835
  • Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J (Ott). 2018;1:4–5. doi:10.1177/1715163517745517
  • Van Oosterwijck J, Nijs J, Meeus M, et al. Pain neurophysiology education improves cognitions, pain thresholds, and movement performance in people with chronic whiplash: a pilot study. J Rehabil Res Dev. 2011;48(1):43–58. doi:10.1682/jrrd.2009.12.020621328162
  • Louw A, Zimney K, O’Hotto C, Hilton S. The clinical application of teaching people about pain. Physiother Theory Pract. 2016;32(5):385–395. doi:10.1080/09593985.2016.119465227351903
  • Lee H, McAuley JH, Hübscher M, Kamper SJ, Traeger AC, Moseley GL. Does changing pain-related knowledge reduce pain and improve function through changes in catastrophizing? Pain. 2016;157(4):922–930. doi:10.1097/j.pain.000000000000047226761387
  • Moseley GL, Butler DS. Fifteen years of explaining pain: the past, present, and future. J Pain. 2015;16(9):807–813. doi:10.1016/j.jpain.2015.05.00526051220
  • Shaikh M, Hapidou EG. Factors involved in patients’ perceptions of self-improvement after chronic pain treatment. Can J Pain. 2018;2(1):145–157. doi:10.1080/24740527.2018.1476821
  • Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academies Press (US); 2001. Executive Summary. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222271 
  • Bergeson SC, Dean JD. A systems approach to patient-centered care. JAMA. 2006;296(23):2848–2851. doi:10.1001/jama.296.23.284817179462
  • Sasakamoose J, Bellegarde T, Sutherland W, Pete S, McKay-McNabb K. Miýo-pimātisiwin developing Indigenous Cultural Responsiveness Theory (ICRT): improving indigenous health and well-being. Int Indig Policy J. 2017;8(4). doi:10.18584/iipj.2017.8.4.1
  • Edgoose JYC, Quiogue M, Sidhar K. How to identify, understand, and unlearn implicit bias in patient care. Fam Pract Manag. 2019;26(4):29–33.31287266
  • Wylie L, McConkey S. Insiders’ insight: discrimination against indigenous peoples through the eyes of health care professionals. J Racial Ethn Health Disparities. 2019;6(1):37–45. doi:10.1007/s40615-018-0495-929736617
  • Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: meta-analysis and systematic review. Am J Emerg Med. 2019;37(9):1770–1777. doi:10.1016/j.ajem.2019.06.01431186154
  • Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci. 2016;113(16):4296. doi:10.1073/pnas.151604711327044069
  • Webster F, Connoy L, Sud A, Pinto AD, Katz J. Grappling with chronic pain and poverty during the COVID-19 pandemic. Can J Pain. 2020;4(1):125–128. doi:10.1080/24740527.2020.1766855
  • Lynch ME, Williamson OD, Banfield JC. COVID-19 impact and response by Canadian pain clinics: a national survey of adult pain clinics. Can J Pain. 2020;4(1):204–209. doi:10.1080/24740527.2020.1783218
  • Peacock S, Patel S. Cultural influences on pain. Reviews in Pain. 2008;1(2):6–9. doi:10.1177/204946370800100203
  • Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217–21. doi:10.1080/08897077.2014.930372
  • Purkey E, Patel R. Phillips SP. Trauma-informed care: Better care for everyone. Canadian Family Physician. 2018;64(3):170–172.